Call for Abstract

17th World Congress on Dementia & Alzheimer’s Disease, will be organized around the theme “New Scientific Discoveries and Technologies in Dementia Research”

Euro Dementia Congress 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Dementia Congress 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Alzheimer's disease (AD) is the most widely recognized type of dementia among more established individuals. Dementia is a cerebrum issue that truly influences an individual's capacity to do day by day exercises. Promotion starts gradually. It initially includes the pieces of the mind that control thought, memory and language. Individuals with AD may experience difficulty recalling things that happened as of late or names of individuals they know. In AD, after some time, side effects deteriorate. Individuals may not perceive relatives. They may experience difficulty talking, perusing or composing. They may overlook how to brush their teeth or brush their hair. Later on, they may end up on edge or forceful, or meander far from home. In the end, they need all out consideration. This can cause extraordinary worry for relatives who must think about them. No treatment can stop the ailment. Be that as it may, a few medications may help shield indications from deteriorating temporarily.

 

  • Track 1-1Risk Factors of Alzheimer’s
  • Track 1-2Treatments of Alzheimer’s
  • Track 1-3Clinical Studies of Alzheimer’s
  • Track 1-4Alzheimer’s disease Pathophysiology and Disease Mechanisms

Lewy body dementia, otherwise called dementia with Lewy bodies, is the second most basic sort of dynamic dementia after Alzheimer's infection dementia. Protein stores, called Lewy bodies, create in nerve cells in the mind areas associated with intuition, memory and development (engine control). Lewy body dementia causes a dynamic decrease in mental capacities. Individuals with Lewy body dementia may encounter visual mind flights and changes in readiness and consideration. Different impacts incorporate Parkinson's illness like signs and side effects, for example, inflexible muscles, moderate development and tremors.

  • Track 2-1Lewy body disorders
  • Track 2-2Muscle rigidity
  • Track 2-3Neurotransmitter abnormalities
  • Track 2-4Symptoms of lewy body dementia
  • Track 2-5Advances in lewy body dementia research

Vascular Dementia is that the second most regular reason for insanity once Alzheimer's Diseases. Vascular changes that begin in mind territories that assume a key half in putt away and sick information could cause memory misfortune that appears particularly like Alzheimer's disease sickness. Vascular dementedness may be a decrease in intuition skills caused by conditions that sq.or diminish blood stream to the brain, denying mind cells of fundamental oxygen and supplements. Deficient blood stream can harm and, in the end, dead cells anyplace in the body. The mind has one in all the body's richest systems of veins and is especially helpless. In tube insanity, changes in speculation talents currently so happen suddenly following strokes that sq. important neural structure veins. A developing variety of specialists lean toward the expression "Vascular cognitive Impairment (VCI)" to "vascular dementia”. A few examinations have discovered that vascular changes and different neural structure irregularities could associate in ways in which improve the chance of dementedness finding. The analysis of dementia or mild psychological electric resistance is affirmed by neurocognitive testing, which has some hours of composed or mechanized tests that offer purpose by purpose assessment of reasoning skills, for instance, judgment, arranging, crucial thinking, thinking and memory.

It occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

 

  • Track 3-1Vascular Dementia Prognosis
  • Track 3-2Young onset Dementia
  • Track 3-3Multi-infarct Dementia
  • Track 3-4Mixed Dementia
  • Track 3-5Parkinson Dementia
  • Track 3-6Advances in Vascular Dementia therapy

A psychiatric disorder may also cause physical symptoms, such as a headache, back pain, or stomach pain. If you’re being evaluated for a psychiatric disorder, be sure to tell your doctor about any physical symptoms you’re having, including unexplained aches and pains. Mental health nursing or psychiatry nursing is the speciality of nursing that cares for people of all ages with mental distress or illness such as schizophrenia, bipolar disorder, depression, psychosis it is a stressful and emotionally draining job as well as a rewarding job for once career.

 

  • Track 4-1Depression
  • Track 4-2Personality disorders
  • Track 4-3Anxiety disorders
  • Track 4-4Schizophrenia
  • Track 4-5Eating disorders
  • Track 4-6Addictive behaviors

Alzheimer’s disease Biomarkers, with emphasis on cerebrospinal fluid biomarkers and neuroimaging. Mild Cognitive Impairment (MCI) of Neuroimaging-biomarkers allow an early diagnosis in preclinical stages of Alzheimer’s disease. Biomarker changes in patients with late-onset AD, including findings from studies using structural and functional magnetic resonance imaging (MRI), advanced MRI techniques (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion), positron emission tomography with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers, and CSF protein levels. The dynamic measures of these imaging biomarkers are used to predict the disease progression in the early stages and improve the assessment of therapeutic efficacy in these diseases in future clinical trials.

 

  • Track 5-1Neurogenesis & Neuron Regeneration
  • Track 5-2Neuropathology
  • Track 5-3Cerebrospinal fluid biomarker
  • Track 5-4Structural and functional biomarkers

Dementia, including Alzheimer's malady, is one of the greatest worldwide general wellbeing difficulties confronting our age. Around the world, at any rate 44 million individuals are living with dementia this number is relied upon to twofold by 2030 and more than triple by 2050 to 115 million. A great part of the expansion will be in creating nations like Western Europe and North America. Effectively 62% of individuals with dementia live in creating nations. Today, more than 35 million individuals overall as of now live with the condition. This number is required to twofold by 2030 and more than triple by 2050 to 115 million. No medicines accessible to moderate or stop the cerebrum harm brought about by Alzheimer's infection, a few prescriptions can incidentally help improve the side effects of dementia for certain individuals. In two decades, it is assessed that 1.4 million Canadians will have dementia, costing the economy nearly $300 billion every year. Universally, dementia cost $600 billion every year.

Amyloid is the protein this is delivered clearly by means of the mind every single through one lifetime, however by and large corrupts. On the psyche of Alzheimer’s patients, amyloid aggregates and this amassing pulverizes mind cells. The development of amyloid plaques and neurofibrillary tangles are idea to make commitments to the corruption of the neurons (nerve cells) in the cerebrum and the accompanying side effects of Alzheimer's issue. One of the signs of Alzheimer's disease is the development of amyloid plaques between nerve cells (neurons) inside the cerebrum. Amyloid is an across the board term for protein sections that the body creates normally. Beta amyloid is a protein part clipped from an amyloid antecedent protein (APP). In a solid personality, those protein sections are separated and expelled. In Alzheimer's infirmity, the parts aggregate to shape intense, insoluble plaques.

 

 

  • Track 6-1Cerebrum aggregation of poisonous amyloid β (Aβ)
  • Track 6-2Amyloid Plaques and Neurofibrillary Tangles
  • Track 6-3Amyloid neuroimaging and biomarkers
  • Track 6-4Amyloidosis and Neurodegeneration
  • Track 6-5Aβ affidavit, comprehension and mind volume
  • Track 6-6The amyloid theory and potential medications

The unsafe augmentation in nervous system science the rate and power of Dementia parallels developing masses across over high, focus and low-pay countries. Advantageous discovering, prosperity related individual fulfilment and medicine disclosure for patients living with Dementia, in any case, are extraordinarily lacking. Moreover with Alzheimer's ailment, moving age is an imperative risk ascertains for vascular dementia. To comprehend this assurance, ask about necessities, data organization parts, and alternative structures for consent are required. In particular, facilitated exertion between Dementia research and care, and change in the receptiveness of genomic and prosperity data inside standard scientists should be progressed across over edges.

Ageing: Not being able to remember details of a conversation or event that took place a year ago, not being able to remember the name of an acquaintance, forgetting things and events occasionally, occasionally have difficulty finding words, you are worried about your memory but your relatives are not.

Dementia: Not being able to recall details of recent events or conversations, not recognizing or knowing the names of family members, Forgetting things or events more frequently, frequent pauses and substitutions when finding words, your relatives are worried about your memory, but you are not aware of any problems.

 

 

  • Track 7-1Neuro-anatomical changes in Ageing
  • Track 7-2Risk factors of Cognitive decline
  • Track 7-3Granulovacuolar Degeneration
  • Track 7-4Changes in Cerebral Cortical microvasculature
  • Track 7-5Advances of research in Ageing and Dementia

Individuals with Dementia and vascular dementia have distinctive mental component setbacks that consolidate each memory prevention, that impacts the flexibility to find new information or survey information effectively learned, and one or additional of the resulting symptoms aphasia, apraxia, agnosia, or authority brokenness to such a degree, that the psychological component deficiencies unfavorably influence social or activity working with a noteworthy decline in past capacities. Moreover, individuals with dementia regularly experience the evil impacts of comorbid conditions that additional befuddle psyche and square best outcomes. Thusly, making providing care methods people with vascular dementia is squeezing, given this extending regularity and subsequently the related weight that dementia places not simply on the general population, anyway on the parental figures, relations, and consequently the advantages of the human administrations structure. Conventional viewpoints bearing on geriatric nursing usually portray the consideration as being moderate paced certain and less mentioning than extraordinary consideration. In any case, care of the developed, and particularly those with vascular dementia, is typically frustrated, abnormal, and wobbly.

 

  • Track 8-1Dementia Nursing care plan
  • Track 8-2Music therapy in Dementia
  • Track 8-3Dementia Physiotherapy
  • Track 8-4Clinical features of dementia
  • Track 8-5Dementia Therapeutic intervention

The brain ordinarily therapists to some degree in solid maturing in any case, shockingly, does not lose neurons in huge numbers. In Alzheimer's sickness, be that as it may, harm is across the board, the same number of neurons quit working, lose associations with different neurons, and pass on. Alzheimer's disturbs forms fundamental to neurons and their systems, including correspondence, digestion, and repair. Acetylcholine is a neurotransmitter that is insufficient in individuals with Alzheimer's, the place beginning memory misfortune is trailed by more far reaching changes in considering and conduct that prompt lost freedom. Numerous molecular and cell changes happen in the mind of a man with Alzheimer's illness.

 

  • Track 9-1Amyloid Plaques
  • Track 9-2Neurofibrillary Tangles
  • Track 9-3Chronic Inflammation
  • Track 9-4Vascular Contributions to Alzheimer’s Disease
  • Track 9-5Loss of Neuronal Connections and Cell Death

Most continuous endeavors to battle Alzheimer Disease are centered around treating its clinical symptoms, however the neuropathologic changes fundamental  show up decades sooner and turn out to be basically irreversible when the sickness achieves its clinical stages.This requires treating at preclinical stages, which requires a superior comprehension of the essential instruments prompting Alzheimer Disease pathology. Alzheimer's infection is a complex hereditary issue that is the main source of dementia in the elderly. Atomic confirmation raised the presumptions that trafficking of the amyloid precursor protein is under control of insulin flagging. Most progressing endeavors to battle Alzheimer infection are centered around treating its clinical side effects, however the neuropathologic changes fundamental show up decades sooner and turn out to be basically irreversible when the ailment achieves its clinical stages.

 

  • Track 10-1Fixing Genetic risk for Alzheimer’s
  • Track 10-2Medial Temporal Lobe
  • Track 10-3Nervous System Disease
  • Track 10-4Neurofibrillary Degeneration

To evaluate the safety and efficacy of an oral investigational drug in individuals who are asymptomatic and at-risk for Alzheimer's disease and investigating the effect of crenezumab infusion on Alzheimer's disease progression in individuals with prodromal or mild Alzheimer's disease. Presently the clinical trials and studies are mainly concentrates on Alzheimer’s Disease & Down syndrome, aging to have the best chance of changing the outlook for people with dementia promising ideas must be driven through the development process and into clinical trials in people as quickly as possible.

 

  • Track 11-1Targeting Amyloid
  • Track 11-2Ramping Up the Immune System
  • Track 11-3Non-Medication Approaches
  • Track 11-4Treatment trials
  • Track 11-5Diagnostic studies

Doctors can't analyse  Alzheimer's Disease until after death, when they can nearly inspect the brain under a magnifying instrument. However, they can utilize tests to decide out different conditions that may cause similar symptoms. Early, exact finding is advantageous for a few reasons. Starting treatment ahead of schedule in the illness procedure may help protect day by day working for quite a while, even though the hidden Alzheimer's procedure can't be ceased or switched. Alzheimer's dementia comes about because of the dynamic misfortune (degeneration) of brain cells. This movement may appear in an assortment of courses in brain scans. At present researchers are exploring a few ailment markers and demonstrative tests, for example, qualities, infection related proteins and imaging methods, which may precisely and dependably show whether you have Alzheimer's dementia or not. whatever, right now more research on these tests is important for future

 

  • Track 12-1Diagnostic Tests
  • Track 12-2Neuropsychological testing
  • Track 12-3Treatments for Behavior
  • Track 12-4Biomarker Research
  • Track 12-5Precision Medicine for Alzheimer Disease

Molecular biological research has considerably deepened our understanding of the pathophysiological basis of Alzheimer's dementia. Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. Some genetic risk factors have been identified so far, but only a small proportion of AD cases can be explained by specific gene mutations. Genes may be related to disease in two ways: through autosomal-dominant mutations, in themselves sufficient to cause the disease alternatively, gene variations (polymorphisms) may indirectly increase disease risk without being sufficient in themselves to cause the disorder.

 

  • Track 13-1Molecular Genetics of Frontotemporal Dementia
  • Track 13-2Molecular Genetics of Neurodegenerative Dementias
  • Track 13-3Human stem cell models of dementia
  • Track 13-4Fixing Genetic risk for Alzheimer’s

Novel Therapeutic Technology Inc. (NTT) is a main pioneer in the advancement of complex and down to earth sedate conveyance frameworks. NTT's Ethosome innovation gives the way to fundamentally improve tranquilize entrance of topical conveyance applications, exponentially expanding remedial proficiency. With overall perceived medications joined with NTT know-how, Pharmaceutical organizations can acquaint new and better medications with the market, along these lines incredibly lessening symptoms, improving patient consistence, and expanding the patient's personal satisfaction. Novel therapeutics is a standout amongst the most energizing uses of data preparing frameworks is in diagnostics and treatment. This is not astonishing, given that illness analysis is in its center a data handling undertaking that finishes with a choice. In numerous infections, the conclusion can be performed in singular cells.

 

  • Track 14-1Novel therapeutics strategies for Dementia
  • Track 14-2Novel therapeutics technology
  • Track 14-3Novel therapeutics molecule
  • Track 14-4Anti-dementia drugs
  • Track 14-5Novel drug target for the treatment of dementia